Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study

European Journal of Cancer Care

Volumn 26, Issue 2, 2017, Pages

  Arber, A ^a   Odelius, A ^a   Williams, P ^a   Lemanska, A ^a   Faithfull, S ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

haematopoietic; oral chemotherapy; patient information

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

ATTITUDE TO HEALTH; CHEMICALLY INDUCED; CLINICAL NURSE SPECIALIST; CONSTIPATION; DIARRHEA; FEMALE; FEVER; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NAUSEA; NEOPLASMS; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; QUESTIONNAIRE; SELF CARE; UNITED KINGDOM;

ADMINISTRATION, ORAL; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CONSTIPATION; DIARRHEA; FEMALE; FEVER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NAUSEA; NEOPLASMS; NURSE CLINICIANS; PERIPHERAL NERVOUS SYSTEM DISEASES; SELF CARE; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 84949604924     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12413     Document Type: Article

References (34)

1. Atkins L. & Fallowfield L. (2006) Intentional and non-intentional adherence to medication amongst breast cancer patients. European Journal of Cancer 42, 2271–2276.
2. Barron T.I., Connolly R. & Bennett K. (2007) Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 209, 832–839.
3. Bassan F., Peter F., Houbre B., Brennstuhl M.J., Costantini M., Speyer E. & Tarquinio C. (2013) Adherence to oral antineoplastic agents by cancer patients: definition and literature review. European Journal of Cancer Care 23, 22–35.
4. Cancer Research UK (2014). Available at: http://publications.cancerresearchuk.org/downloads/Product/CS_KF_MYELOMA.pdf (accessed 3 November 2014).
5. Chau I., Legge S. & Fumoleau P. (2004) The vital role of education in information in patients receiving capecitabine. European Journal of Oncology Nursing 8, S41–S53.
6. Cramer J.A., Roy A., Fairchild C.J. & Fuldeore M.J. (2008) Medication compliance and persistence: terminology and definition. Value Health 11, 44–47.
7. De Mario M.D. & Ratain M.J. (1998) Oral chemotherapy: rationale and future directions. Journal of Clinical Oncology 16, 2557–2567.
8. Gerbrecht B.M. & Kangas T. (2004) Implications of capecitabine (Xeloda) for cancer nursing practice. European Journal of Oncology Nursing 8(Suppl. 1), S63–S71.
9. Hartigan K. (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clinical Journal of Oncology Nursing 7, 21–24.
10. Haynes R.B., Yao X. & Degani A. (2005) Interventions to enhance medication adherence. Cochrane Database of Systematic Review 4, CD000011.
11. Lebovits A.H., Strain J.J., Scheifer S.J., Tanaka J.S., Bhardwaj S. & Messe M.R. (1990) Patient non observence with self-administered chemotherapy. Health Psychology 9, 405–417.
12. Linn A.J., vanWeert J.C.M., Schouten B.C., Smit E.G., van Bodegraven A.A. & van Dijk L. (2012) Word that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behaviour. Patient Preference and Adherence 6, 871–885.
13. Liu G., Franssen E., Fitch M. & Warner E. (1997) Patient preference for oral versus intravenous palliative chemotherapy. Journal of Clinical Oncology 15, 110–115.
14. McCoy L. (2009) Time, self and the medication day: a closer look at the everyday work of ‘adherence’. Sociology of Health and Illness 31, 128–146.
15. Miloh T., Annunziato R. & Arnon R. (2009) Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 124, 844–850.
16. Moliatossis A., Wilson B., Blair S., Howe T. & Cavet J. (2011) Living with multiple myeloma: experience of patients and their informal caregivers. Supportive Care in Cancer 19, 101–111.
17. Morgan G.J., Krishnan B., Jenner M. & Davies F.E. (2006) Advances in oral therapy for multiple myeloma. Lancet Oncology 7, 316–325.
18. Multinational Association for Supportive Care in Cancer (2014) MASCC oral agent teaching tool (MOATT). Available at: www.mascc.org (accessed 3 November 2014).
19. Noens L., van Lierde M.-A., De Bock R. & Verhof G. (2009) Prevelance, determinants and outcomes of non adherence to imatinib therapy in patients with chronic myeloid leukaemia the ADAGIO study. Blood 109, 3496–3499.
20. Oakley C. (2005) “It is a lot easier to cope with”. An exploration of cancer patients’ experience of oral chemotherapy. Unpublished MSc Dissertation. Kings College, London University, UK.
21. Oakley C., Johnson J. & Ream E. (2010) Developing an intervention for cancer patients pescribed oral chemotherapy: a generic patient diary. European Journal of Cancer Care 19, 21–28.
22. O'Neil V.J. & Twelves C.J. (2002) Oral cancer treatment: developments in chemotherapy and beyond. British Journal of Cancer 87, 933–937.
23. Partridge A.H., Avorn J., Wang P.S. & Winer E.P. (2002) Adherence to therapy with oral antineoplastic agents. Journal of the National Cancer Institute 94, 652–661
24. Regnier Denois V., Poirson J., Nourissat A., Jacquin J.-P., Guastalla J.P. & Chauvi F. (2011) Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. European Journal of Cancer Care 20, 520–527.
25. Ruddy K., Mayer E. & Partridge A. (2009) Patient adherence and persistence with oral anticancer treatment. CA: A Cancer Journal for Clinicians 59, 56–66.
26. Simonchowitz B., Shuman L. & Spencer J. (2010) Perceptions and experiencs of patients receiving oral chemotherapy. Clinical Journal of Oncology Nursing 14, 447–453.
27. Skalla K.A., Bakitas M., Furstenberg C.T., Ahles T. & Henderson J.V. (2004) Patients’ need for information about cancer therapy. Oncology Nursing Forum 31, 313–319.
28. Stephenson F.A., Cox K., Britten N. & Dundar Y. (2004) Communication between patients and health care professionals about medicines: the consequences for concordance. Health Expectations 7, 235–245.
29. Thomas D.R. (2006) A general inductive approach for analyzing qualitative evaluation data. American Journal of Evaluation 27, 237–246.
30. Thorne S., Oliffe J.L., Oglov V. & Gelmon K. (2013) Communication challenges for chronic metastatic cancer in an era of novel therapeutics. Qualitative Health Research 23, 863–877.
31. Weingart S.N., Flug J., Brouillard D., Morway L., Partridge A., Bartel S., Shulman L.N. & Connor M. (2007) Oral chemotherapy safety practices at US cancer centres: questionnaire survey. British Medical Journal 334, 407–411.
32. Weingart S.N., Brown E. & Bach P.B. (2008) National Comprehensive Cancer Network Task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network 6(Suppl. 3), 1–14.
33. Wolpin S. (2009) Improving Medication Adherence for Patients with Low Functional Health Literacy. Department of Health & Human Services, University of Washington, Seattle, WA, USA.
34. World Health Organization (2008) Definitions. Available at: http://www.who.int/hac/about/definitions/en/ (accessed 3 November 2014).